HN2000000166A - Composicion de ovulos intravaginales de clindamicina - Google Patents

Composicion de ovulos intravaginales de clindamicina

Info

Publication number
HN2000000166A
HN2000000166A HN2000000166A HN2000000166A HN2000000166A HN 2000000166 A HN2000000166 A HN 2000000166A HN 2000000166 A HN2000000166 A HN 2000000166A HN 2000000166 A HN2000000166 A HN 2000000166A HN 2000000166 A HN2000000166 A HN 2000000166A
Authority
HN
Honduras
Prior art keywords
clindamycin
composition
intravaginal
ovules
dispersed
Prior art date
Application number
HN2000000166A
Other languages
English (en)
Inventor
Carolyn V Pesheck
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of HN2000000166A publication Critical patent/HN2000000166A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION COMPRENDE UNA COMPOSICION PARA LA ADMINISTRACION INTRAVAGINAL DE CLINDAMICINA QUE CONTIENE UNA CANTIDAD ANTIMICROBIANA EFICAZ DE CLINDAMICINA DISPERSADA EN UNA BASE DE GRASA SOLIDA NF.
HN2000000166A 1999-08-06 2000-08-02 Composicion de ovulos intravaginales de clindamicina HN2000000166A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14756199P 1999-08-06 1999-08-06

Publications (1)

Publication Number Publication Date
HN2000000166A true HN2000000166A (es) 2001-04-20

Family

ID=22522061

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2000000166A HN2000000166A (es) 1999-08-06 2000-08-02 Composicion de ovulos intravaginales de clindamicina

Country Status (24)

Country Link
US (2) US6495157B1 (es)
EP (1) EP1200065B1 (es)
JP (1) JP2003519095A (es)
KR (1) KR100670085B1 (es)
CN (1) CN1160056C (es)
AR (1) AR025045A1 (es)
AT (1) ATE250408T1 (es)
AU (1) AU768907B2 (es)
CA (1) CA2378572A1 (es)
DE (1) DE60005524T2 (es)
DK (1) DK1200065T3 (es)
ES (1) ES2207532T3 (es)
HK (1) HK1047538A1 (es)
HN (1) HN2000000166A (es)
MA (1) MA26749A1 (es)
MX (1) MXPA02001320A (es)
NZ (1) NZ517039A (es)
PA (1) PA8499101A1 (es)
PE (1) PE20010484A1 (es)
PT (1) PT1200065E (es)
SI (1) SI1200065T1 (es)
SV (1) SV2001000138A (es)
TW (1) TWI232111B (es)
WO (1) WO2001010407A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
WO2004014338A1 (en) * 2002-02-05 2004-02-19 Pharmacia & Upjohn Company Composition and method for rectal delivery of a lincosamide antibacterial drug
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648407A4 (en) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
AU2004264939A1 (en) 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
BRPI0414500A (pt) * 2003-09-19 2006-11-07 Drugtech Corp formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
US20070065504A1 (en) * 2004-03-23 2007-03-22 Lin Shun Y Products and methods for treating vaginal infections
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20060078616A1 (en) * 2004-08-30 2006-04-13 Georgewill Dawaye A Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
US20070110805A1 (en) * 2005-05-09 2007-05-17 Levinson R S Modified-release pharmaceutical compositions
CN100446774C (zh) * 2005-05-31 2008-12-31 黑龙江龙桂制药有限公司 盐酸克林霉素阴道泡腾片及其制备方法
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
EA200870153A1 (ru) * 2006-01-05 2008-12-30 Драгтек Корпорейшн Композиция и способ ее использования
US20070154516A1 (en) * 2006-01-05 2007-07-05 Drugtech Corporation Drug delivery system
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
DE102009055644A1 (de) * 2009-11-25 2011-06-01 Nicole Nedela Dildo-Set
CN103735491B (zh) * 2013-12-31 2016-01-13 哈尔滨欧替药业有限公司 克林霉素磷酸酯阴道膨胀栓及其制备方法和检测方法
US10695301B2 (en) 2018-09-04 2020-06-30 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
US10813963B2 (en) 2018-09-04 2020-10-27 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
WO2021177938A1 (en) * 2020-03-02 2021-09-10 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
MX2020011523A (es) * 2020-10-29 2022-05-02 Exeltis Pharma Mexico S A De C V Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2812683B2 (ja) * 1988-07-26 1998-10-22 富士製薬工業株式会社 持続性を有するモルヒネ直腸投与製剤
JPH05213752A (ja) * 1992-02-06 1993-08-24 Fujisawa Asutora Kk 坐 剤
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
DE19737348C2 (de) * 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition

Also Published As

Publication number Publication date
DK1200065T3 (da) 2004-02-02
SV2001000138A (es) 2001-10-24
DE60005524T2 (de) 2004-08-05
KR20020038713A (ko) 2002-05-23
HK1047538A1 (en) 2003-02-28
CN1160056C (zh) 2004-08-04
EP1200065B1 (en) 2003-09-24
PT1200065E (pt) 2004-02-27
DE60005524D1 (de) 2003-10-30
US20020197320A1 (en) 2002-12-26
AU768907B2 (en) 2004-01-08
NZ517039A (en) 2003-01-31
PE20010484A1 (es) 2001-04-20
MA26749A1 (fr) 2004-12-20
ES2207532T3 (es) 2004-06-01
CA2378572A1 (en) 2001-02-15
AU6219800A (en) 2001-03-05
US6495157B1 (en) 2002-12-17
CN1360495A (zh) 2002-07-24
EP1200065A1 (en) 2002-05-02
MXPA02001320A (es) 2004-09-10
KR100670085B1 (ko) 2007-01-17
ATE250408T1 (de) 2003-10-15
PA8499101A1 (es) 2001-12-14
WO2001010407A1 (en) 2001-02-15
TWI232111B (en) 2005-05-11
JP2003519095A (ja) 2003-06-17
AR025045A1 (es) 2002-11-06
SI1200065T1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
HN2000000166A (es) Composicion de ovulos intravaginales de clindamicina
DE60131138D1 (de) Antibakterielle mittel
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
HN2002000153A (es) Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester.
DK1416921T3 (da) Oxycodon-formuleringer til indgivelse én gang dagligt
HN2002000150A (es) Agentes antibacteriano
NO20024221L (no) Blandinger inneholdende alfa-2-adrenerge agonistkomponenter
PA8624601A1 (es) Macrolidos y metodos para producir los mismos
DK1317177T3 (da) Desinficerende formuleringer
DK1401501T3 (da) Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
ECSP044981A (es) Composicion oftalmica que comprende ascomicina
BRPI0514723A (pt) composições contendo componentes de agonista alfa-2-adrenérgico
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
NO20005332D0 (no) Forkjølelsesmiddel med isomalt som virksom bestanddel
ITTO20020789A1 (it) Formulazione solida
ATE315380T1 (de) Epothilon zusammensetzungen
ITMI20031714A1 (it) Formazioni ad azione antitumorale.
ES2153875T3 (es) Agentes antitromboticos.
BR0112600A (pt) Compostos calcilìticos
DE60135023D1 (de) Trennmittelzusammensetzung
GT200100218A (es) Compuesto agroquimico.
DK1326845T3 (da) N-Alkoxyalkyl-substituerede benzimidazoler samt deres anvendelse som midler mod parasiterende protozoer
NO20032086D0 (no) Adjuvant kombinasjonsformuleringer
NO20031239D0 (no) 1-amino-alkylsykloheksaner som trypanocidale midler
DOP2002000329A (es) Composicion solida